Continuous infusion versus intermittent boluses of furosemide in acute heart failure: A systematic review and meta-analysis.

  title={Continuous infusion versus intermittent boluses of furosemide in acute heart failure: A systematic review and meta-analysis.},
  author={Jeffrey Shi Kai Chan and Thompson Ka Ming Kot and Nancy Marcus and Amer Harky},
  journal={Journal of cardiac failure},
6 Citations
It is concluded that AHF is a clinical syndrome with still high mortality and rehospitalization rates and that the timely diagnosis and treatment may favourably affect the prognosis.
Ventricular Septal Rupture following Anterior Acute Myocardial Infarction: A Challenge to a Sub-District Physician
Every clinician especially in the low-resource setting should be aware of this potentially fatal mechanical complication as the mortality remains significantly high.
A Fast and Validated HPLC Method for Simultaneous Determination of Dopamine, Dobutamine, Phentolamine, Furosemide, and Aminophylline in Infusion Samples and Injection Formulations
The results of the stability study showed that mixtures of DPM, DBM, PTM, FSM, and APL in 5% glucose or 0.9% sodium chloride injection were stable for 48 hours when stored in polypropylene syringes at 25°C.
Insuficiencia cardiaca aguda, de la evolución del concepto de la congestión al tratamiento
La insuficiencia cardiaca (IC) es una pandemia que contribuye en gran parte a la morbi-mortalidad cardiovascular, esta entidad nos enfrenta a grandes retos durante los episodios de descompensación o


Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta‐analysis of randomised controlled trials
There was no difference between continuous infusion and bolus of furosemide for all‐cause mortality, length of hospital stay and electrolyte disturbance, but continuous infusion was superior to bolus administration with regard to diuretic effect and reduction in brain natriuretic peptide.
Continuous infusion of furosemide versus intermittent boluses in acute decompensated heart failure: Effect on thoracic fluid content
Continuous Versus Bolus Dosing of Furosemide in the Treatment of Patients with Acute Decompensated Heart Failure
Both continuous infusion and bolus dose diuretic modality of treatment have equal role in the management of ADHF with no significant difference in the renal function and electrolytes level.
Short and long-term effects of continuous versus intermittent loop diuretics treatment in acute heart failure with renal dysfunction
Intravenous loop diuretics are still the cornerstone of therapy in acute decompensated heart failure, however, the optimal dosage and administration strategies remain poorly defined particularly in
Clinical effects and safety of different strategies for administering intravenous diuretics in acutely decompensated heart failure: a randomised clinical trial
In patients with ADHF attending the ED, boluses of furosemide have a smaller diuretic effect but provide similar clinical relief, similar preservation of renal function, and a lower incidence of hypokalaemia than continuous infusion.
Diuretic strategies in patients with acute decompensated heart failure.
Among patients with acute decompensated heart failure, there were no significant differences in patients' global assessment of symptoms or in the change in renal function when diuretic therapy was administered by bolus as compared with continuous infusion or at a high dose asCompared with a low dose.
Comparison of three diuretic treatment strategies for patients with acute decompensated heart failure
Administration of furosemide plus HSS may be the preferred diuretic strategy because of its shorter hospital stay and there was no significant difference in the mean change in serum creatinine level between groups.